TY - JOUR
T1 - Malaria
T2 - Current status of control, diagnosis, treatment, and a proposed agenda for research and development
AU - Guerin, Philippe J.
AU - Olliaro, Piero
AU - Nosten, Francois
AU - Druilhe, Pierre
AU - Laxminarayan, Ramanan
AU - Binka, Fred
AU - Kilama, Wen L.
AU - Ford, Nathan
AU - White, Nicholas J.
PY - 2002/9
Y1 - 2002/9
N2 - Rolling back malaria is possible. Tools are available but they are not used. Several countries deploy, as their national malaria control treatment policy, drugs that are no longer effective. New and innovative methods of vector control, diagnosis, and treatment should be developed, and work towards development of new drugs and a vaccine should receive much greater support. But the pressing need, in the face of increasing global mortality and general lack of progress in malaria control, is research into the best methods of deploying and using existing approaches, particularly insecticide-treated mosquito nets, rapid methods of diagnosis, and artemisinin-based combination treatments. Evidence on these approaches should provide national governments and international donors with the cost-benefit information that would justify much-needed increases in global support for appropriate and effective malaria control.
AB - Rolling back malaria is possible. Tools are available but they are not used. Several countries deploy, as their national malaria control treatment policy, drugs that are no longer effective. New and innovative methods of vector control, diagnosis, and treatment should be developed, and work towards development of new drugs and a vaccine should receive much greater support. But the pressing need, in the face of increasing global mortality and general lack of progress in malaria control, is research into the best methods of deploying and using existing approaches, particularly insecticide-treated mosquito nets, rapid methods of diagnosis, and artemisinin-based combination treatments. Evidence on these approaches should provide national governments and international donors with the cost-benefit information that would justify much-needed increases in global support for appropriate and effective malaria control.
UR - http://www.scopus.com/inward/record.url?scp=0036724848&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036724848&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(02)00372-9
DO - 10.1016/S1473-3099(02)00372-9
M3 - Comment/debate
C2 - 12206972
AN - SCOPUS:0036724848
SN - 1473-3099
VL - 2
SP - 564
EP - 573
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 9
ER -